Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of etoposide in treating patients with
relapsed non-Hodgkin's lymphoma.